Other News To Note
Tuesday, October 15, 2013
• Dual Therapeutics LLC, of Cleveland, was formed by drug development accelerator Biomotiv LLC, of Cleveland, and the Icahn School of Medicine at Mount Sinai to develop therapeutics for prostate and lung cancer and acute lymphoblastic leukemia.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.